Skip to content

Raltegravir may have role in PEP if exposure involves drug-resistant HIV

Excellent outcomes from five years of antiretroviral use in Botswana

Study explores verbal and non-verbal communication in unprotected sex between men

IL-2 provides quick ‘AIDS rescue’, but effect does not always last

Second-line combinations fail twice as often as first-line ones in the first year

Once-a-day etravirine should work as first-line treatment

One in five Kenyan patients suffers major interactions between HIV drugs and other medicines

If you can't switch, better to stay on failing treatment than stop it, studies show

Non-nucleoside resistance is efficiently transmitted within infection ‘clusters’